Hearing Loss Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For all participants:
- People who are over 18 years old
- People who are covered by a social security system
- People who have a good understanding of French, both spoken and written
For the group with age-related hearing loss (anticipated presbycusis):
- People over 40 who currently use a hearing aid or are getting one for the first time
- People between 18 and 40 who currently use a hearing aid, are getting one for the first time, or have a progressive genetic hearing condition present from birth
For healthy volunteers:
- People who have no known hearing loss
Who may not be able to join:
- People who have been regularly exposed to loud sounds over a long period of time
- People who have a history of exposure to substances known to damage hearing
- People who have lasting effects from ear infections, or a history of ear, nose, or throat conditions that permanently affect hearing or balance
- People whose ethnic background is one for which the Pasteur Institute does not have data on the specific genes being studied (confirm with trial site)
- People who have type 2 diabetes
- People who have a neurological or psychiatric condition that affects their understanding or ability to move
- People who are under legal guardianship
- People whose freedom is restricted by a court or government decision, or who are under legal protection
- People who are not covered by a social security system
- People who are taking narcotics, alcohol, or medications that reduce cognitive abilities
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Paul Avan, MD, CERIAH
Phone: +33 (0)1 76 53 50 29
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Measurement of specificity and sensitivity of the audiological test battery in participants with early-onset presbycusis after identification of pathogenic variants by sequencing and division into subgroups.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.